The weekly litigation news digest is live. Subscribe now
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs - EP3127551
The patent EP3127551 was granted to Boehringer Ingelheim Animal Health USA on Jul 29, 2020. The application was originally filed on Dec 28, 2006 under application number EP16185663A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
EP3127551
- Application Number
- EP16185663A
- Filing Date
- Dec 28, 2006
- Status
- Granted And Under Opposition
- Jun 26, 2020
- Publication Date
- Jul 29, 2020
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Patent Oppositions (3)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent Citations (18) New
Patent citations refer to prior patents cited during different phases such as opposition or international search.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents